Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma (MM)”

382 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 382 results

Testing effectiveness (Phase 2)Study completedNCT00320476
What this trial is testing

VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates

Who this might be right for
Multiple Myeloma
Korean Multiple Myeloma Working Party 35
Early research (Phase 1)Ended earlyNCT02579824
What this trial is testing

Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Myeloma
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT01394354
What this trial is testing

Vorinostat in Combination With Bortezomib, Doxorubicin and Dexamethasone (VBDD) in Patients With Refractory or Relapsed Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma in Relapse
University Hospital Freiburg 34
Not applicableUnknownNCT04727294
What this trial is testing

MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance+1 more
HealthTree Foundation 1,500
Early research (Phase 1)Active Not RecruitingNCT05775094
What this trial is testing

Romosozumab in Women With Multiple Myeloma and Osteoporosis

Who this might be right for
OsteoporosisMultiple Myeloma
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Ended earlyNCT00648739
What this trial is testing

Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaMultiple Myeloma
Alexion Pharmaceuticals, Inc. 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04649073
What this trial is testing

Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Otsuka Pharmaceutical Co., Ltd. 11
Testing effectiveness (Phase 2)UnknownNCT05749133
What this trial is testing

Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
XuYan 18
Testing effectiveness (Phase 2)UnknownNCT01114048
What this trial is testing

Early Response-adapted Intensification of Induction Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Chonnam National University Hospital 78
Not applicableNot Yet RecruitingNCT06925958
What this trial is testing

A Clinical Trial Evaluating the Safety Tolerability, Radiation Absorption Dose, Distribution, PET Imaging and Histological Expression of 68Ga-NOTA-SCH001 in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
The First Affiliated Hospital of Soochow University 15
Testing effectiveness (Phase 2)Looking for participantsNCT05998928
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of Therapy

Who this might be right for
Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Not applicableUnknownNCT03405571
What this trial is testing

Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias.

Who this might be right for
Multiple MyelomaVenous Thromboembolism
University of Athens 800
Testing effectiveness (Phase 2)Study completedNCT00065351
What this trial is testing

Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 222
Early research (Phase 1)Ended earlyNCT04887259
What this trial is testing

Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML

Who this might be right for
Chronic Lymphocytic LeukemiaMultiple MyelomaAcute Myeloid Leukemia
Lava Therapeutics 16
Large-scale testing (Phase 3)UnknownNCT01134484
What this trial is testing

VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Michele Cavo 480
Early research (Phase 1)Study completedNCT03269136
What this trial is testing

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 101
Early research (Phase 1)Study completedNCT02211014
What this trial is testing

An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Acerta Pharma BV 27
Not applicableEnded earlyNCT02761187
What this trial is testing

An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants

Who this might be right for
Multiple Myeloma
Takeda 4,253
Testing effectiveness (Phase 2)Ended earlyNCT00396383
What this trial is testing

Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation

Who this might be right for
Multiple Myeloma
Genzyme, a Sanofi Company 9
Not applicableNot Yet RecruitingNCT07353554
What this trial is testing

Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Peking Union Medical College Hospital 30
Load More Results